| 艾瑞婷.瑞典生命科学发展现状[J].全球科技经济瞭望,2015,30(3):32~36 |
| 瑞典生命科学发展现状 |
| Development of Life Science in Sweden |
| 投稿时间：2014-12-07 |
| DOI：10.3772/j.issn.1009-8623.2015.03.007 |
| 中文关键词: 瑞典；生命科学；生物和医药技术；生命科学产业 |
| 英文关键词: Sweden；life science；biological and medical technology；life science industry |
| 基金项目: |
|
| 摘要点击次数: 2830 |
| 全文下载次数: 1887 |
| 中文摘要: |
| 当前，生命科学领域的发展已成为全球关注的焦点。很多国家都将生命科学列为重点发展领域
之一。瑞典在生命科学研究领域一直保持国际先进水平，生命科学产业是瑞典主要的出口产业。面对日趋激烈的国际竞争，瑞典政府发布“2013-2016 年研究与创新法案”，宣布投资 19.6 亿克朗支持生命科学发展，重点研究方向包括：传染病和抗生素研究、老年病研究、药物研发、临床治疗技术改进以及临床实验研究等。本文分析了瑞典生命科学领域科研体制和科研经费情况、近年重点研究方向及产业概
况，并对瑞典生命科学发展现状进行了概述。 |
| 英文摘要: |
| Nowadays, the development of life science has become the focus of global attention. Many
countries have put life science as a priority in their national program. Swedish research in the life science
maintains a high standard and companies in this area account for a large part of Swedish export success. In order
to maintain Sweden’s position in the life science in the world, the “2013-2016 Research and Innovation Bill”
announced that the government would allocate 1.96 billion SEK to support life science development. The priority
fields include the infectious disease and antibiotic research, gerontology research, pharmaceutical R&D, clinical
treatment improvement, and so on. In this article, the present status of Swedish’s life science will be analyzed from
three perspectives, including mechanism and funding of the research, priorities in recent years and the industry
profiles. This will give a comprehensive understanding of the status of the bioscience in Sweden. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
